MiNK Therapeutics, Inc. (INKT) NASDAQ

11.12

-0.03(-0.27%)

Updated at January 02 04:00PM

Currency In USD

Valuation

Market Cap26.09M
Enterprise Value26.44M
P/E Ratio-0.01
PEG Ratio0
Price/Sales Ratio0.01
Price/Book Ratio0
Enterprise/Revenue-3.77
Enterprise/EBITDA1,569.49

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-1.5
Operating Margin-0

Management Effectiveness

Return On Assets-0.38
Return On Equity340.18

Income Statement

Revenue0
Revenue/Share848.4
Gross Profit-215,437
EBITDA-10.57M
Net Income-10.78M
Diluted EPS-2.8

Balance Sheet

Total Cash14.28M
Total Cash/Share3,214.32
Total Debt5.73M
Total Debt/Equity0
Current Ratio1.08
Book Value Per Share3,367.92

Price History

52-Week Change23.28
52-Week High76
52-Week Low4.56
Moving Average 50 Days12.36
Moving Average 200 Days12.03

Statistics

Average Volume22,424
Shares Outstanding4.69M
% Held by Institutions0

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateJanuary 28, 2025